WO2006004696A3 - Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline - Google Patents

Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline Download PDF

Info

Publication number
WO2006004696A3
WO2006004696A3 PCT/US2005/022812 US2005022812W WO2006004696A3 WO 2006004696 A3 WO2006004696 A3 WO 2006004696A3 US 2005022812 W US2005022812 W US 2005022812W WO 2006004696 A3 WO2006004696 A3 WO 2006004696A3
Authority
WO
WIPO (PCT)
Prior art keywords
insulin
control
compositions
prevention
methods
Prior art date
Application number
PCT/US2005/022812
Other languages
English (en)
Other versions
WO2006004696A2 (fr
Inventor
Daniel T Green
Robert R Henry
Original Assignee
Diobex Inc
Daniel T Green
Robert R Henry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diobex Inc, Daniel T Green, Robert R Henry filed Critical Diobex Inc
Priority to EP05787795A priority Critical patent/EP1778266A4/fr
Priority to MXPA06014970A priority patent/MXPA06014970A/es
Priority to CA002571030A priority patent/CA2571030A1/fr
Priority to AU2005260025A priority patent/AU2005260025A1/en
Priority to JP2007519344A priority patent/JP2008505087A/ja
Publication of WO2006004696A2 publication Critical patent/WO2006004696A2/fr
Publication of WO2006004696A3 publication Critical patent/WO2006004696A3/fr
Priority to IL180361A priority patent/IL180361A0/en
Priority to NO20070174A priority patent/NO20070174L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques comprenant de l'insuline et du glucagon et pouvant être administrées en vue de réguler et de traiter le diabète tout en réduisant ou en supprimant le risque d'hypoglycémie induite par l'insuline.
PCT/US2005/022812 2004-06-29 2005-06-27 Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline WO2006004696A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP05787795A EP1778266A4 (fr) 2004-06-29 2005-06-27 Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline
MXPA06014970A MXPA06014970A (es) 2004-06-29 2005-06-27 Composiciones y metodos para la prevencion y el control de la hipoglucemia inducida por la insulina.
CA002571030A CA2571030A1 (fr) 2004-06-29 2005-06-27 Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline
AU2005260025A AU2005260025A1 (en) 2004-06-29 2005-06-27 Compositions and methods for the prevention and control of insulin-induced hypoglycemia
JP2007519344A JP2008505087A (ja) 2004-06-29 2005-06-27 インスリン誘発性低血糖の予防および制御のための組成物ならびに方法
IL180361A IL180361A0 (en) 2004-06-29 2006-12-26 Compositions and methods for the prevention and control of insulin-induced hypoglycemia
NO20070174A NO20070174L (no) 2004-06-29 2007-01-10 Preparater og fremgangsmater for forebyggelse og kontroll av insulindindusert hypoglykemi

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58444904P 2004-06-29 2004-06-29
US60/584,449 2004-06-29

Publications (2)

Publication Number Publication Date
WO2006004696A2 WO2006004696A2 (fr) 2006-01-12
WO2006004696A3 true WO2006004696A3 (fr) 2006-10-26

Family

ID=35783298

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/022812 WO2006004696A2 (fr) 2004-06-29 2005-06-27 Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline

Country Status (11)

Country Link
EP (1) EP1778266A4 (fr)
JP (1) JP2008505087A (fr)
KR (1) KR20070029276A (fr)
CN (1) CN101001638A (fr)
AU (1) AU2005260025A1 (fr)
CA (1) CA2571030A1 (fr)
IL (1) IL180361A0 (fr)
MX (1) MXPA06014970A (fr)
NO (1) NO20070174L (fr)
WO (1) WO2006004696A2 (fr)
ZA (1) ZA200700708B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2533601T3 (es) 2010-11-03 2015-04-13 Arecor Limited Nueva composición que comprende glucagón
JP7001584B2 (ja) * 2015-09-04 2022-01-19 ラティチュード ファーマシューティカルズ インコーポレイテッド 安定化されたグルカゴン溶液
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
CN110446496A (zh) * 2017-02-03 2019-11-12 范德比尔特大学 用于治疗糖尿病的系统、组合物和方法
CA3069533A1 (fr) * 2017-07-14 2019-01-17 Xeris Pharmaceuticals, Inc. Methodes de traitement d'hyperinsulinisme congenital
WO2019108640A1 (fr) * 2017-11-28 2019-06-06 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Procédés et kits pour évaluer le métabolisme

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
US20040110817A1 (en) * 2002-11-18 2004-06-10 Pfizer Inc Dipeptidyl peptidase IV inhibiting fluorinated cyclic amides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897551A (en) * 1971-04-05 1975-07-29 Lilly Co Eli Iodoglucagons and process for prolonging the biological activity of glucagon
US7314859B2 (en) * 2002-12-27 2008-01-01 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
US20040110817A1 (en) * 2002-11-18 2004-06-10 Pfizer Inc Dipeptidyl peptidase IV inhibiting fluorinated cyclic amides

Also Published As

Publication number Publication date
ZA200700708B (en) 2009-03-25
IL180361A0 (en) 2007-06-03
MXPA06014970A (es) 2007-03-07
WO2006004696A2 (fr) 2006-01-12
JP2008505087A (ja) 2008-02-21
AU2005260025A1 (en) 2006-01-12
EP1778266A2 (fr) 2007-05-02
CN101001638A (zh) 2007-07-18
NO20070174L (no) 2007-03-13
EP1778266A4 (fr) 2009-09-09
KR20070029276A (ko) 2007-03-13
CA2571030A1 (fr) 2006-01-12

Similar Documents

Publication Publication Date Title
MXPA05006994A (es) Composiciones y metodos para la prevencion y el control de hipoglucemia inducida por insulina.
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
WO2005020892A3 (fr) Compositions pharmaceutiques et procedes de modulation metabolique
WO2007081824A3 (fr) Protéines résistantes à la fibrillation
MX2013004699A (es) Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos.
WO2007084314A3 (fr) MODULATEURS de la 11-ß HYDROXYSTEROIDE DESHYDROGENASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCEDES D'UTILISATION
WO2008082602A3 (fr) Composes et compositions pharmaceutiques destines au traitement des troubles hepatiques
WO2010092163A3 (fr) Médicaments antidiabétiques
WO2007139941A3 (fr) Composition et procédés de traitement de l'insuffisance cardiaque globale
WO2007128817A3 (fr) Dérivé insulinique
WO2005009398A3 (fr) Derives de benzamide tetracyclique et leurs procedes d'utilisation
MY173828A (en) A composition for treating diabetes or diabesity comprising oxyntomodulin analog
WO2010030054A3 (fr) Utilisations de dérivés de sesquiterpène
WO2008054695A3 (fr) Composition et procédé pour le traitement étiologique et la prévention de maladies et/ou de complications associées à la déstabilisation chronique du métabolisme du glucose
WO2006004696A3 (fr) Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline
WO2007018588A8 (fr) Composition pharmaceutique stable comprenant la forme iv de linézolide
WO2010028132A3 (fr) Nouveaux co-cristaux de choline et d'épalrestat
WO2009035534A3 (fr) Traitement d'une maladie ischémique de l'œil par activation pharmaceutique systématique d'un facteur induit par l'hypoxie (hif)
WO2010011926A3 (fr) Nouveau co-cristal de bétaïne d'épalrestat
AU2012207301A8 (en) Apolipoprotein AIV as an antidiabetic peptide
EA200800338A1 (ru) Профилактика и лечение офтальмологических осложнений диабета
WO2006133194A3 (fr) Methodes permettant de traiter une infection virale a l'aide d'une solution medicamenteuse orale ou injectable
TW200633702A (en) Medicinal composition containing fbpase inhibitor
WO2005039627A3 (fr) Applications therapeutiques pour peptide c
AU2003212672A1 (en) Pharmaceutical composition comprising an extract or compounds isolated from elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/014970

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2571030

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007519344

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 180361

Country of ref document: IL

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 2005787795

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 258/KOLNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2005260025

Country of ref document: AU

Ref document number: 200700708

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 552860

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1020077002164

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 200580027047.6

Country of ref document: CN

ENP Entry into the national phase

Ref document number: 2005260025

Country of ref document: AU

Date of ref document: 20050627

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2005260025

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1020077002164

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2005787795

Country of ref document: EP